Autopsy report · NCT01470313

A Multiple Dose Study Of PD-0360324 In Patients With Active Cutaneous Lupus Erythematosus

Cause of deathNo reason given Automatic label, confidence 0.9, unverified. How labels are made.

“See termination reason in detailed description.”

The sponsor’s own words in the registry.

Life of this trial

Ran for about 2 years before it stopped.
28 participants enrolled.
No results are posted on the registry.

Vital statistics

Status: Terminated
Phase: Phase 1
Sponsor: Pfizer
Sponsor type: Industry
Conditions: Cutaneous Lupus Erythematosus
Interventions: PD-0360324; Placebo
Participants: 28
Sites: 19
Countries: Canada, Moldova, United States

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.